SWP
ETON icon

Stratos Wealth Partners’s Eton Pharmaceutcials ETON Stock Holding History

Stratos Wealth Partners’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-26,878
Closed -$118K – 1408
2023
Q4 		$118K Hold
26,878
– – ﹤0.01% 1317
2023
Q3 		$112K Sell
26,878
-31,147
-54% -$120K ﹤0.01% 1224
2023
Q2 		$203K Sell
58,025
-34,285
-37% -$126K ﹤0.01% 1103
2023
Q1 		$355K Buy
+92,310
New +$337K 0.01% 809

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.43M AUM 17.52% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Stratos Wealth Partners's ETON Position: Q1 2024 in Review

Stratos Wealth Partners sold out of Eton Pharmaceutcials (ETON) in Q1 2024, closing a stake of 26,878 shares — an estimated $118K sold.

Stratos Wealth Partners first reported a position in ETON in Q1 2023 and held it in 4 quarters. The position peaked at $355K in Q1 2023. 44 funds tracked by Wall St. Rank hold ETON as of Q1 2024.

  • Stratos Wealth Partners reported no remaining Eton Pharmaceutcials position as of Q1 2024 after selling out during the quarter.
  • Stratos Wealth Partners sold 26,878 Eton Pharmaceutcials shares in Q1 2024, an estimated $118K.
  • Stratos Wealth Partners first reported a position in Eton Pharmaceutcials in Q1 2023 and held it in 4 quarters.
  • Stratos Wealth Partners's Eton Pharmaceutcials position peaked at $355K in Q1 2023.
  • 44 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2024.

Based on Stratos Wealth Partners's 13F filing for Q1 2024, filed 16 Apr 2024.